Effects of different therapeutic methods on the 90-day prognosis of patients with HBV-ACLF: A systematic review and network meta-analysis
This meta-analysis showed that MSC + PE was the most effective therapy in improving the 90-day prognosis, and G-CSF was the potential optimal monotherapy in improving the 90-day prognosis of HBV-ACLF patients.
Authors
- Hua Yin (ORCID: https://orcid.org/0000-0002-1322-4156)
- Yongning Xin (ORCID: https://orcid.org/0000-0002-3692-7655)
- Shousheng Liu (ORCID: https://orcid.org/0000-0002-2613-3237)
- Hui Liu (ORCID: https://orcid.org/0000-0003-0611-1572)
- Yuqin He (ORCID: https://orcid.org/0000-0001-7208-247X)
Institutions
- Qingdao University (CN)
- Qingdao Municipal Hospital (CN)
- Wuxi People's Hospital (CN)
- Qingdao Eighth People's Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1097/md.0000000000046388
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00